PROVISTA DIAGNOSTICS, INC.
SCOTTSDALE, AZ

PROVISTA DIAGNOSTICS, INC., SCOTTSDALE

Provista’s highly experienced leadership team has a proven track record in successfully commercializing new diagnostic products. The team operates from the company’s core values that stress candor in all communications, integrity across business facets, and the courage to pursue a bold vision to improve the detection and monitoring of women’s cancers. Products & Pipeline to Address Unmet Needs in Women’s Cancers Videssa Breast is the first blood test of its kind to detect the presence or absence of breast cancer in women with abnormal or difficult-to-interpret mammographic findings. When used in combination with imaging, Videssa Breast can improve diagnostic accuracy and provide greater confidence and clarity when clinical assessment is challenging. Videssa Breast offers clarity for healthcare providers who must navigate complex decisions in women who present with difficult-to-interpret findings. Provista Diagnostics Laboratory Provista Diagnostics Laboratory

KEY FACTS ABOUT PROVISTA DIAGNOSTICS, INC.

Company name
PROVISTA DIAGNOSTICS, INC.
Status
Inactive
Filed Number
F13000000684
FEI Number
27-4282214
Date of Incorporation
February 13, 2013
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://provistadiagnostics.com
Phones
(855) 552-7439
(844) 552-7439

PROVISTA DIAGNOSTICS, INC. NEAR ME

Principal Address
17301 N. PERIMETER DR.,
SCOTTSDALE,
AZ,
85255,
US

See Also

Officers and Directors

The PROVISTA DIAGNOSTICS, INC. managed by the three persons from SCOTTSDALE, Scottsdale on following positions: Chief Executive Officer, CFO, Director

Gary G Altman

Position
Chief Executive Officer Active
From
SCOTTSDALE, AZ, 85255

Uriel E Kusiatin

Position
CFO Active
From
SCOTTSDALE, AZ, 85255

John Fermanis

Position
Director Active
From
Scottsdale, AZ, 85255





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

September 27, 2019
REVOKED FOR ANNUAL REPORT

Annual Reports

2018
April 19, 2018
2017
May 1, 2017